17h
Oxford’s new Ebola vaccine enters first human trial: Serum Institute making over 6,20,000 doses
The CEPI-backed vaccine against the Bundibugyo strain of Ebola has reached Phase 1 trials just 57 days after the outbreak was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results